GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75N93022C00058INTRAVACC B.V.

Overview

Award facts

Net obligations
$6.61M
$6,612,767of $14.61M potential value
Outlays (paid to date)
$3.64M
$3.64M paid of $6.61M obligated$3,639,902
Period of performance
Sep 21, 2022 to Dec 30, 2026
Ends in 1 month
Modifications
11
Latest action Jan 14, 2026
Contract type
Definitive contract
PIID 75N93022C00058

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

DEVELOPMENT OF AN INTRANASAL VACCINE AGAINST GONORRHEA BASED ON OUTER MEMBRANE VESICLES COMBINED WITH SUSTAINED-RELEASE MICROSPHERES CONTAINING RECOMBINANT HUMAN INTERLEUKIN-12.

Dates and value

Award date
Signed on Sep 21, 2022
Potential end of performance
Dec 29, 2026
Current value
$6,612,767Base and exercised options
Potential value (if all options are exercised)
$14,613,141

Obligations by fiscal year of action

  • FY2025: $1,174,464
  • FY2024: $2,674,055
  • FY2023: $756,750
  • FY2022: $2,007,498

Total across 4 fiscal years: $6,612,767

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 14, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationBILTHOVEN, NLD
UEIRY3NEWMNZA63
CAGE codeH2MN6
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyINTRAVACC B.V.

Business types and certifications

Foreign-ownedFor-profit organizationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Netherlands

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost no feeS
Offers received
10

Solicitation and notices

Solicitation ID
2021-1
Solicitation date
Feb 23, 2021
Notices

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Yes - CAS clause includedY
Certified cost or pricing data
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 21, 2022Base obligation at award: $2,007,498
Latest action
Jan 14, 2026 — Other administrative actionModification P00011; administrative: no change in scope or value
Latest substantive action
May 16, 2025 — Option exercisedModification P00008; obligation change +$1,174,464
Actions by type
  • Base award1
  • Other administrative action8
  • Option exercised3
12 actions recorded, Sep 21, 2022 to Jan 14, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
Foreign-owned business not incorporated in the U.S.D
Country of product or service origin
NetherlandsNLD
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
12

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
  • 075-2024/2024-0885-000
  • 075-2025/2025-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression